Virgin Galactic Pushes First Commercial Flight to February 2027, Secures $50M+ in Oversubscribed Expeditions
SPCE sits 37% above its 52-week low of $2.13.
Summary
Virgin Galactic reported Q2 2026 results with a $56M net loss and delayed its first commercial flight to February 2027, but oversubscribed a $750K expedition tranche adding $50M+ to future revenue and guided to positive quarterly cash flow within 2027.
Key Events · Earnings and Guidance · SPCE
-
First Commercial Flight Delayed to Feb 2027
First commercial spaceflight moves from Q4 2026 to February 2027 to complete avionics and systems installations; flight test phase begins October 2026.
-
Oversubscribed Expedition Tranche Adds $50M+
Recent tranche of spaceflight expeditions priced at $750,000 booked out ahead of schedule and oversubscribed, representing over $50 million in expected future spaceflight revenue.
-
Positive Quarterly Cash Flow Expected Within 2027
Management expects to deliver positive quarterly cash flow within 2027, supported by second spaceship joining the fleet in March 2027.
-
Q2 2026 Financial Results
Revenue of $0.1M, net loss of $56M, free cash flow of $(91)M, and cash/marketable securities of $286M as of June 30, 2026.
Analysis · SPCE · Energy & Transportation
Virgin Galactic's Q2 2026 results show a $56 million net loss and $91 million free cash burn, but the real story is the timeline shift: first commercial spaceflight slips from Q4 2026 to February 2027 to complete avionics and systems installations. Against that delay, the company booked out a tranche of $750,000 spaceflight expeditions ahead of schedule, adding over $50 million to expected future revenue, and guided to positive quarterly cash flow within 2027. The company also raised $134 million through its ATM program during the quarter, extending its cash runway to $286 million in cash and marketable securities.
At the time of this filing, SPCE was trading at $2.91 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $442.3M. The 52-week trading range was $2.13 to $8.90. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.